pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
413
stories
May 6, 26
Dr Pant on the Mechanism of Action of Daraxonrasib in PDAC
onclive
May 6, 26
CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine
biopharma dive
May 5, 26
Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic Cancer
onclive
May 5, 26
Dr Pant on Managing Toxicities With Daraxonrasib in PDAC
onclive
May 5, 26
STAT+: A new attack on AMA’s billing codes
stat
May 5, 26
Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer Congress
onclive
May 5, 26
Viridian data lift prospects for thyroid eye disease drug
biopharma dive
May 5, 26
The Type of Fat—Not the Amount—Fuels Pancreatic Cancer
onclive
May 5, 26
STAT+: Are analysts too quick to gloss over Lilly’s liver case?
stat
May 5, 26
Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCC
onclive
May 5, 26
STAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more
stat
May 5, 26
Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosis
onclive
May 5, 26
Vertex earnings get muted investor response
biopharma dive
May 5, 26
Coordinating Care in Multiple Myeloma Across Practice Settings
onclive
May 5, 26
STAT+: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease
stat
May 5, 26
Cytospire hauls in $83M for a new type of T cell engager
biopharma dive
May 5, 26
STAT+: Johnson & Johnson advances IBD therapy, despite trial miss
stat
May 4, 26
Researchers urge study of paternal deaths, though a new paper finds fatherhood is protective
stat
May 4, 26
STAT+: Pump the brakes on AI, buddy; and deposition deadlock
stat
May 4, 26
UCB to acquire maker of antibody treatments for autoimmune diseases
stat
May 4, 26
STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news
stat
May 4, 26
UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases
biopharma dive
May 4, 26
UCB bets $2B on Candid's T cell engager ambitions
endpoints
May 1, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
May 1, 26
Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
biopharma dive
May 1, 26
‘Forever chemicals’ in baby formula? Scientists unpack FDA results
stat
Apr 29, 26
AbbVie faces questions about Skyrizi competition from J&J
endpoints
Apr 29, 26
Teva nabs experimental Tourette drug in $700M Emalex buyout
biopharma dive
Apr 28, 26
Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development
stat
Apr 28, 26
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
biopharma dive
← prev
page 13 of 14
next →
